Treatment for Hypocalcemia
The treatment for hypocalcemia should include oral calcium supplementation (preferably calcium carbonate), vitamin D supplementation, and in severe symptomatic cases, intravenous calcium gluconate administration. 1, 2
Clinical Presentation and Assessment
- Hypocalcemia can present with a wide range of symptoms from mild to life-threatening, including neuromuscular irritability, tetany, seizures, fatigue, and cardiac arrhythmias 3
- Common neurological symptoms include paresthesias (tingling/numbness) of hands, feet, and perioral region, muscle cramps, spasms, irritability, and emotional changes 3
- Cardiovascular manifestations include prolongation of QT interval and potentially dangerous arrhythmias 3
- Baseline laboratory tests should include pH-corrected ionized calcium, magnesium, parathyroid hormone (PTH), and creatinine levels 1
Treatment Algorithm
Acute Symptomatic Hypocalcemia
- For severe symptomatic hypocalcemia (tetany, seizures, cardiac arrhythmias):
- Administer intravenous calcium gluconate immediately 2, 4
- Standard dosing for adults: 1-2 grams of calcium gluconate (93-186 mg elemental calcium) via slow IV infusion 2
- Do not exceed an infusion rate of 200 mg/minute in adults or 100 mg/minute in pediatric patients 2
- Monitor ECG during administration to avoid cardiac complications 2
Chronic or Mild Hypocalcemia
- For asymptomatic or mild hypocalcemia:
- Oral calcium supplementation with calcium carbonate as the preferred calcium salt 1
- Typical dosage: 600-1000 mg of elemental calcium daily 1
- Total elemental calcium intake (dietary plus supplements) should not exceed 2,000 mg/day 5, 1
- Daily vitamin D supplementation is recommended for all patients with hypocalcemia 5, 1
- For refractory cases, consider hormonally active vitamin D metabolites like calcitriol 1, 6
- If hypomagnesemia is present, magnesium supplementation is necessary 5, 1
Special Considerations
Chronic Kidney Disease
- For patients with CKD, maintain serum calcium within the normal range, preferably toward the lower end (8.4-9.5 mg/dL) 5
- Consider active vitamin D sterols if PTH is elevated 5
- Therapy for hypocalcemia should include calcium salts and/or oral vitamin D sterols 5
- Monitor calcium-phosphorus product to maintain at <55 mg²/dL² 5
Hypoparathyroidism
- Calcium and vitamin D supplementation must be carefully titrated to avoid symptoms while keeping serum calcium in the low-normal range 7
- Recombinant human PTH (1-84) has been approved for treatment of chronic hypoparathyroidism when standard therapy is inadequate 6
Post-Thyroidectomy Hypocalcemia
- Prophylactic vitamin D supplementation in the immediate preoperative period can significantly reduce acute symptomatic postoperative hypocalcemia 8
Monitoring
- Serum calcium should be measured every 4-6 hours during intermittent infusions and every 1-4 hours during continuous infusion 2
- For chronic management, serum calcium and phosphorus should be measured at least every 3 months after initiating treatment 1
- Targeted monitoring of calcium concentrations is necessary during vulnerable times such as surgery, pregnancy, or acute illness 1, 3
Potential Complications and Pitfalls
- Overcorrection can lead to iatrogenic hypercalcemia, renal calculi, and renal failure 1, 3
- Undercorrection may result in persistent symptoms, seizures, or cardiac arrhythmias 3
- Drug interactions: Hypercalcemia increases the risk of digoxin toxicity; avoid administration of calcium in patients receiving cardiac glycosides 2
- Calcium may reduce the response to calcium channel blockers 2
- For patients with renal impairment, start at the lowest dose of the recommended range and monitor serum calcium levels closely 2